Wellington, New Zealand Clinical Trials

Adenocarcinoma

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical research study of Pembroliziumab and Paclitaxel for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma (MK-3475-061/KEYNOTE-061)

AIDS and AIDS related infections

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study evaluating MK-1439A and ATRIPLA™ for the treatment of Human Immunodeficiency Virus (HIV) (MK-14391-021)

Alzheimer's Disease

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Amnestic Mild Cognitive Impairment, Alzheimer's Disease or Prodromal Alzheimer's Disease

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Alzheimer's Disease

Anemia

CCDHB - Wellington Hospital

A clinical trial to evaluate treatments using Pacritinib and Best Available Therapy for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Arthritis and Arthritic Pain

1301.1.3407 Boehringer Ingelheim Investigational Site

A clinical trial to evaluate treatments for patients with Arthritis, Rheumatoid

Asthma

Research Site

A clinical trial seeking patients for a research study for the treatment of Asthma

Research Site

Patients are needed to participate in a clinical research study evaluating budesonide/formoterol 'as needed' + budesonide placebo bid and budesonode bid + terbutaline 'as needed' for the treatment of Asthma

Atherosclerosis

Research Site Updated

Patients are needed to participate in a clinical research study of Epanova® (omega-3 carboxylic acids) and corn oil control to evaluate Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)

Atrial Fibrillation

Wellington Hospital

A clinical study for patients with Heart Failure or Atrial Fibrillation

Bladder Cancer

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of pembrolizumab, paclitaxel, vinflunine and docetaxel to evaluate Urothelial Cancer

COPD (Chronic Obstructive Pulmonary Disease)

Research Site

A clinical research study of Flutiform 500/20 µg BID, Flutiform 250/10 µg BID and Seretide Accuhaler 50/500 µg BID for the treatment of Chronic Obstructive Pulmonary Disease

GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Crohn's Disease

WaiKato Hospital

A Phase 2 clinical study for patients with Crohn's Disease

Cytomegalovirus Infections

Merck Sharp & Dohme (New Zealand) Ltd.,

A Phase 3 clinical study for patients with Cytomegalovirus Infections

Deep Vein Thrombosis

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Diabetes Mellitus, Type 2

Research Site

A Phase 3 clinical study for patients with Diabetes Mellitus, Type 2 or Diabetic Nephropathies

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical trial seeking patients for a research study for the treatment of Diabetes Mellitus, Type 2

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical research study for the treatment of Type 2 Diabetes Mellitus

Merck Sharp & Dohme (New Zealand) Ltd.,

A clinical trial to evaluate treatments using Sitagliptin, Metformin, Placebo to sitagliptin and Placebo to metformin for patients with Diabetes Mellitus or Type 2 Diabetes

Endometriosis

Site Reference ID/Investigator# 96060

A Phase 3 clinical study for patients with Endometriosis

Fibromyalgia

Research Site

A Phase 3 clinical study for patients with Pain Associated With Fibromyalgia

Gastric Cancer

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical research study of Pembroliziumab and Paclitaxel for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma (MK-3475-061/KEYNOTE-061)

Heart Attack (Myocardial Infarction)

Wellington Hospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Heart Failure

Wellington Hospital

A clinical study for patients with Heart Failure or Atrial Fibrillation

Hepatitis

Merck Sharp & Dohme (New Zealand) Ltd.,

A clinical trial to evaluate treatments using Grazoprevir, MK-3682, Elbasvir and MK-8408 for patients with Hepatitis C

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of Grazoprevir, MK-3682, Elbasvir and MK-8408 to evaluate Hepatitis C Virus (HCV)

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of MK-8408 to evaluate Hepatitis C Infection

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of IDX21437 and Matching Placebo to evaluate Chronic Hepatitis C

Site Reference ID/Investigator# 130916

Patients are needed to participate in a clinical research study evaluating ABT-493, ABT-530 and Ribavirin (RBV) for the treatment of Chronic Hepatitis C Virus (HCV)

High Cholesterol (Hyperlipidemia)

Wellington Hospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

HIV Infections

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study evaluating MK-1439A and ATRIPLA™ for the treatment of Human Immunodeficiency Virus (HIV) (MK-14391-021)

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study evaluating MK-1439A, Baseline regimen of Ritonavir-boosted protease inhibitor and Baseline regimen of two Nucleoside reverse Transcriptase inhibitors for the treatment of HIV-1 Infection

Hypertriglyceridemia

Research Site Updated

Patients are needed to participate in a clinical research study of Epanova® (omega-3 carboxylic acids) and corn oil control to evaluate Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)

Kidney Disease

Research Site

A Phase 3 clinical study for patients with Diabetes Mellitus, Type 2 or Diabetic Nephropathies

Lung Disease

Research Site

A clinical research study of Flutiform 500/20 µg BID, Flutiform 250/10 µg BID and Seretide Accuhaler 50/500 µg BID for the treatment of Chronic Obstructive Pulmonary Disease

GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Lupus

GSK Investigational Site

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Lymphocytic Leukemia, Chronic

Research Site

A clinical trial to evaluate treatments using Chlorambucil, GDC-0199 and Obinutuzumab for patients with Chronic Lymphocytic Leukemia

Malignant Melanoma

Research Site

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Melanoma

Research Site

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

Merck Sharp & Dohme (New Zealand) Ltd.,

A Phase 1/Phase 2 clinical study for patients with Melanoma

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study evaluating Pembrolizumab and placebo for the treatment of Melanoma, High-Risk Stage III Melanoma (MK-3475-054/KEYNOTE-054)

Multiple Sclerosis

P3 Research Updated

A clinical research study of MIS416 and Saline for the treatment of Secondary Progressive Multiple Sclerosis

Myelofibrosis

CCDHB - Wellington Hospital

A clinical trial to evaluate treatments using Pacritinib and Best Available Therapy for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Neoplasm Metastasis

1160.189.64201 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

P3 Research Updated

A clinical research study of MIS416 and Saline for the treatment of Secondary Progressive Multiple Sclerosis

Neoplasms

Research Site

A clinical research study of Trabectedin, DOXIL and Dexamethasone for the treatment of Ovarian Neoplasms, Peritoneal Neoplasms or Fallopian Tube Neoplasms

Non-Small Cell Lung Cancer

Site Reference ID/Investigator# 125755

Patients are needed to participate in a clinical research study of veliparib, carboplatin, paclitaxel and placebo to evaluate Squamous Non-Small Cell Lung Cancer

Site Reference ID/Investigator# 132470

Patients are needed to participate in a clinical research study to evaluate Non-squamous Non-small Cell Lung Cancer

Osteoporosis

Merck Sharp & Dohme (New Zealand) Ltd.,

A Phase 1 clinical study for patients with Osteoporosis

Pain

Research Site

A Phase 3 clinical study for patients with Pain Associated With Fibromyalgia

Pulmonary Embolism

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Renal Cell Carcinoma

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

Rheumatoid Arthritis

1301.1.3407 Boehringer Ingelheim Investigational Site

A clinical trial to evaluate treatments for patients with Arthritis, Rheumatoid

Stroke

1160.189.64201 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Wellington Hospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Systemic Lupus Erythematosus

GSK Investigational Site

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Thromboembolism

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Thrombosis

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Ulcerative Colitis

Bowen Hospital

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

P3 Research Limited

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Pacific Radiology (X-rays only)

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Ulcers

Bowen Hospital

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

P3 Research Limited

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Pacific Radiology (X-rays only)

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Venous Thromboembolism

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Venous Thrombosis

Research Site

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)